Cargando…
Development and Validation of a DeepSurv Nomogram to Predict Survival Outcomes and Guide Personalized Adjuvant Chemotherapy in Non-Small Cell Lung Cancer
OBJECTIVE: To develop and validate a DeepSurv nomogram based on radiomic features extracted from computed tomography images and clinicopathological factors, to predict the overall survival and guide individualized adjuvant chemotherapy in patients with non-small cell lung cancer (NSCLC). PATIENTS AN...
Autores principales: | Yang, Bin, Liu, Chengxing, Wu, Ren, Zhong, Jing, Li, Ang, Ma, Lu, Zhong, Jian, Yin, Saisai, Zhou, Changsheng, Ge, Yingqian, Tao, Xinwei, Zhang, Longjiang, Lu, Guangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260694/ https://www.ncbi.nlm.nih.gov/pubmed/35814402 http://dx.doi.org/10.3389/fonc.2022.895014 |
Ejemplares similares
-
The predictive value of modified-DeepSurv in overall survivals of patients with lung cancer
por: Lei, Jie, et al.
Publicado: (2023) -
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network
por: Katzman, Jared L., et al.
Publicado: (2018) -
Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020) -
Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer
por: Yang, Bin, et al.
Publicado: (2021) -
Development and Validation of a Radiomics Nomogram Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Clinicopathological Factors to Predict the Survival Outcomes of Patients With Non-Small Cell Lung Cancer
por: Yang, Bin, et al.
Publicado: (2020)